Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection-Reference-Cited by-同舟云学术

Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection

Published:2017-10-24 Issue:4 Volume:10 Page:83
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Lima Rui,Monteiro Susana,Lopes José,Barradas Pedro,Vasconcelos Natália,Gomes Eduardo,Assunção-Silva Rita,Teixeira Fábio,Morais Mónica,Sousa Nuno,Salgado António,Silva Nuno

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://www.mdpi.com/1424-8247/10/4/83/pdf

Reference54 articles.

1. Facts and figures at a glance;J. Spinal Cord Med.,2005

2. Cellular inflammatory response after spinal cord injury in sprague-dawley and lewis rats

3. Post-traumatic inflammation following spinal cord injury

4. Anti-Inflammatory Treatments during the Chronic Phase of Spinal Cord Injury Improve Locomotor Function in Adult Mice

5. Inhibition of Monocyte/Macrophage Migration to a Spinal Cord Injury Site by an Antibody to the Integrin αD: A Potential New Anti-inflammatory Treatment

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered T cell therapy for central nervous system injury;Nature;2024-09-04

2. Delayed administration of interleukin-4 coacervate alleviates the neurotoxic phenotype of astrocytes and promotes functional recovery after a contusion spinal cord injury;Journal of Neural Engineering;2024-08-01

3. Lack of Synergistic Outcomes with Roflumilast Combined with Levetiracetam or Adipose Stem Cell Secretome After Spinal Cord Injury;2024-07-04

4. Spinal Cord Injury Management Based on Microglia-Targeting Therapies;Journal of Clinical Medicine;2024-05-08

5. Microglia: a promising therapeutic target in spinal cord injury;Neural Regeneration Research;2024-04-16